Skip to main content
Erschienen in: Supportive Care in Cancer 8/2013

01.08.2013 | Original Article

Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients

verfasst von: Shinichiro Morishita, Katsuji Kaida, Shinya Yamauchi, Koichiro Sota, Shinichi Ishii, Kazuhiro Ikegame, Norihiko Kodama, Hiroyasu Ogawa, Kazuhisa Domen

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to investigate the relationship between corticosteroid dose and degree of physical function decrease in allogeneic hematopoietic stem cell transplantation (allo-HSCT) patients during the early stage of recovery. We further investigated the confounding factors affecting loss of physical function.

Methods

The study included 113 patients who underwent allo-HSCT between July 2007 and April 2012 at Hyogo College of Medicine Hospital in Japan. Physical function was assessed using tests for hand-grip strength, knee-extensor strength, and the 6-min walk test (6MWT). Fatigue was measured using the Piper Fatigue Scale. Total corticosteroid dose, frequency of physical therapy, body weight, and nutritional status were also collected from medical records.

Results

Total corticosteroid dose was correlated with decrease of hand-grip and knee-extensors strength (P < 0.01) but was not correlated with 6MWT performance. Results of multivariate analysis confirmed that low physical function was associated not only with high corticosteroid dose but also with low frequency of physical therapy, increase in fatigue, and body weight loss (P < 0.05). Also, hemoglobin levels were associated with 6MWT (P < 0.05).

Conclusions

This study showed the relationship between corticosteroid dose and declines in physical function and also showed other clinical factors affecting loss of physical function among allo-HSCT patients. Our results indicate that the effectiveness of rehabilitation may be influenced by corticosteroid treatment.
Literatur
1.
Zurück zum Zitat Yoshimi A, Suzuki R, Atsuta Y, Iida M, Lu DP, Tong W, Ghavamzadeh A, Alimoghaddam K, Lie AK, Liang R, Chan LL, Haipeng L, Tan PL, Hwang WY, Chiou TJ, Chen PM, Van Binh T, Minh NN, Min CK, Hwang TJ, Kodera Y, Asia-Pacific Blood and Marrow Transplantation Group (APBMT) (2010) Hematopoietic SCT activity in Asia: a report from the Asia-Pacific blood and marrow transplantation group. Bone Marrow Transplant 45:1682–1691PubMedCrossRef Yoshimi A, Suzuki R, Atsuta Y, Iida M, Lu DP, Tong W, Ghavamzadeh A, Alimoghaddam K, Lie AK, Liang R, Chan LL, Haipeng L, Tan PL, Hwang WY, Chiou TJ, Chen PM, Van Binh T, Minh NN, Min CK, Hwang TJ, Kodera Y, Asia-Pacific Blood and Marrow Transplantation Group (APBMT) (2010) Hematopoietic SCT activity in Asia: a report from the Asia-Pacific blood and marrow transplantation group. Bone Marrow Transplant 45:1682–1691PubMedCrossRef
2.
Zurück zum Zitat Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, de Witte T, Farge-Bancel D, Gaspar B, Marsh J, Mohty M, Peters C, Tichelli A, Velardi A, de Elvira CR, Falkenburg F, Sureda A, Madrigal A, European group for blood and marrow transplantation (EBMT) (2012) The EBMT activity survey: 1990–2010. Bone Marrow Transplant 47:906–923PubMedCrossRef Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, de Witte T, Farge-Bancel D, Gaspar B, Marsh J, Mohty M, Peters C, Tichelli A, Velardi A, de Elvira CR, Falkenburg F, Sureda A, Madrigal A, European group for blood and marrow transplantation (EBMT) (2012) The EBMT activity survey: 1990–2010. Bone Marrow Transplant 47:906–923PubMedCrossRef
3.
4.
Zurück zum Zitat Grulke N, Albani C, Bailer H (2012) Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) quality of life core questionnaire QLQ-C30. Bone Marrow Transplant 47:473–482PubMedCrossRef Grulke N, Albani C, Bailer H (2012) Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) quality of life core questionnaire QLQ-C30. Bone Marrow Transplant 47:473–482PubMedCrossRef
5.
Zurück zum Zitat Tabbara IA, Zimmerman K, Morgan C, Nahleh Z (2002) Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med 162:1558–1566PubMedCrossRef Tabbara IA, Zimmerman K, Morgan C, Nahleh Z (2002) Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med 162:1558–1566PubMedCrossRef
6.
Zurück zum Zitat Gillis T, Donovan E (2001) Rehabilitation following bone marrow transplantation. Cancer 92:998–1007PubMedCrossRef Gillis T, Donovan E (2001) Rehabilitation following bone marrow transplantation. Cancer 92:998–1007PubMedCrossRef
7.
Zurück zum Zitat Gerber LH, Molnar A (2009) Graft-versus-host disease. In: Stubblefield MD, O’Dell MW (eds) Cancer rehabilitation principles and practice. Demos Medical, New York, pp 747–782 Gerber LH, Molnar A (2009) Graft-versus-host disease. In: Stubblefield MD, O’Dell MW (eds) Cancer rehabilitation principles and practice. Demos Medical, New York, pp 747–782
8.
Zurück zum Zitat Kovalszki A, Schumaker GL, Klein A, Terrin N, White AC (2008) Reduced respiratory and skeletal muscle strength in survivors of sibling or unrelated donor hematopoietic stem cell transplantation. Bone Marrow Transplant 41:965–969PubMedCrossRef Kovalszki A, Schumaker GL, Klein A, Terrin N, White AC (2008) Reduced respiratory and skeletal muscle strength in survivors of sibling or unrelated donor hematopoietic stem cell transplantation. Bone Marrow Transplant 41:965–969PubMedCrossRef
9.
Zurück zum Zitat Hacker ED, Larson J, Kujath A, Peace D, Rondelli D, Gaston L (2011) Strength training following hematopoietic stem cell transplantation. Cancer Nurs 34:238–249PubMedCrossRef Hacker ED, Larson J, Kujath A, Peace D, Rondelli D, Gaston L (2011) Strength training following hematopoietic stem cell transplantation. Cancer Nurs 34:238–249PubMedCrossRef
10.
Zurück zum Zitat Danaher EH, Ferrans C, Verlen E, Ravandi F, van Besien K, Gelms J, Dieterle N (2006) Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum 33:614–624PubMedCrossRef Danaher EH, Ferrans C, Verlen E, Ravandi F, van Besien K, Gelms J, Dieterle N (2006) Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum 33:614–624PubMedCrossRef
11.
Zurück zum Zitat Morishita S, Kaida K, Setogawa K, Kajihara K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K (2012) Safety and feasibility of physical therapy in cytopenic patients during allogeneic haematopoietic stem cell transplantation. Eur J Cancer Care (Engl). doi:10.1111/ecc.12027 Morishita S, Kaida K, Setogawa K, Kajihara K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K (2012) Safety and feasibility of physical therapy in cytopenic patients during allogeneic haematopoietic stem cell transplantation. Eur J Cancer Care (Engl). doi:10.​1111/​ecc.​12027
12.
Zurück zum Zitat Baumann FT, Zopf EM, Nykamp E, Kraut L, Schüle K, Elter T, Fauser AA, Bloch W (2011) Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention. Eur J Haematol 87:148–156PubMedCrossRef Baumann FT, Zopf EM, Nykamp E, Kraut L, Schüle K, Elter T, Fauser AA, Bloch W (2011) Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention. Eur J Haematol 87:148–156PubMedCrossRef
13.
Zurück zum Zitat Morishita S, Kaida K, Yamauchi S, Wakasugi T, Yoshihara S, Taniguchi K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K (2012) Gender differences in health-related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation. Psychooncology. doi:10.1002/pon.3128 Morishita S, Kaida K, Yamauchi S, Wakasugi T, Yoshihara S, Taniguchi K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K (2012) Gender differences in health-related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation. Psychooncology. doi:10.​1002/​pon.​3128
14.
Zurück zum Zitat Salmasian H, Rohanizadegan M, Banihosseini S, Rahimi Darabad R, Rabbani-Anari M, Shakiba A, Ferrara JL (2010) Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation. Cochrane Database Syst Rev 1:CD005565PubMed Salmasian H, Rohanizadegan M, Banihosseini S, Rahimi Darabad R, Rabbani-Anari M, Shakiba A, Ferrara JL (2010) Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation. Cochrane Database Syst Rev 1:CD005565PubMed
15.
Zurück zum Zitat Menconi M, Fareed M, O’Neal P, Poylin V, Wei W, Hasselgren PO (2007) Role of glucocorticoids in the molecular regulation of muscle wasting. Crit Care Med 35:S602–S608PubMedCrossRef Menconi M, Fareed M, O’Neal P, Poylin V, Wei W, Hasselgren PO (2007) Role of glucocorticoids in the molecular regulation of muscle wasting. Crit Care Med 35:S602–S608PubMedCrossRef
16.
Zurück zum Zitat Natsui K, Tanaka K, Suda M, Yasoda A, Sakuma Y, Ozasa A, Ozaki S, Nakao K (2006) High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass. Osteoporos Int 17:105–108PubMedCrossRef Natsui K, Tanaka K, Suda M, Yasoda A, Sakuma Y, Ozasa A, Ozaki S, Nakao K (2006) High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass. Osteoporos Int 17:105–108PubMedCrossRef
17.
Zurück zum Zitat Fardet L, Flahault A, Kettaneh A, Tiev KP, Généreau T, Tolédano C, Lebbé C, Cabane J (2007) Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion. Br J Dermatol 157:142–148PubMedCrossRef Fardet L, Flahault A, Kettaneh A, Tiev KP, Généreau T, Tolédano C, Lebbé C, Cabane J (2007) Corticosteroid-induced clinical adverse events: frequency, risk factors and patient’s opinion. Br J Dermatol 157:142–148PubMedCrossRef
18.
Zurück zum Zitat Nava S, Fracchia C, Callegari G, Ambrosino N, Barbarito N, Felicetti G (2002) Weakness of respiratory and skeletal muscles after a short course of steroids in patients with acute lung rejection. Eur Respir J 20:497–499PubMedCrossRef Nava S, Fracchia C, Callegari G, Ambrosino N, Barbarito N, Felicetti G (2002) Weakness of respiratory and skeletal muscles after a short course of steroids in patients with acute lung rejection. Eur Respir J 20:497–499PubMedCrossRef
19.
Zurück zum Zitat Qian T, Guo X, Levi AD, Vanni S, Shebert RT, Sipski ML (2005) High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord 43:199–203PubMedCrossRef Qian T, Guo X, Levi AD, Vanni S, Shebert RT, Sipski ML (2005) High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord 43:199–203PubMedCrossRef
20.
Zurück zum Zitat Hopkinson NS, Man WD, Dayer MJ, Ross ET, Nickol AH, Hart N, Moxham J, Polkey MI (2004) Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease. Eur Respir J 24:137–142PubMedCrossRef Hopkinson NS, Man WD, Dayer MJ, Ross ET, Nickol AH, Hart N, Moxham J, Polkey MI (2004) Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease. Eur Respir J 24:137–142PubMedCrossRef
21.
Zurück zum Zitat Lee HJ, Oran B, Saliba RM, Couriel DM, Shin K, Massey P, Neumann J, de Lima M, Champlin R, Giralt S (2006) Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy. Bone Marrow Transplant 38:299–303PubMedCrossRef Lee HJ, Oran B, Saliba RM, Couriel DM, Shin K, Massey P, Neumann J, de Lima M, Champlin R, Giralt S (2006) Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy. Bone Marrow Transplant 38:299–303PubMedCrossRef
22.
Zurück zum Zitat Okada M, Fujimori Y, Misawa M, Kai S, Nakajima T, Okikawa Y, Satake A, Itoi H, Takatsuka H, Itsukuma T, Nishioka K, Tamaki H, Ikegame K, Hara H, Ogawa H (2008) Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies. Biol Blood Marrow Transplant 14:896–903PubMedCrossRef Okada M, Fujimori Y, Misawa M, Kai S, Nakajima T, Okikawa Y, Satake A, Itoi H, Takatsuka H, Itsukuma T, Nishioka K, Tamaki H, Ikegame K, Hara H, Ogawa H (2008) Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies. Biol Blood Marrow Transplant 14:896–903PubMedCrossRef
23.
Zurück zum Zitat Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I (2006) Unmanipulated HLA 2–3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. Biol Blood Marrow Transplant 12:1073–1084PubMedCrossRef Ogawa H, Ikegame K, Yoshihara S, Kawakami M, Fujioka T, Masuda T, Taniguchi Y, Hasei H, Kaida K, Inoue T, Kim EH, Kawase I (2006) Unmanipulated HLA 2–3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. Biol Blood Marrow Transplant 12:1073–1084PubMedCrossRef
24.
Zurück zum Zitat Ogawa H, Ikegame K, Kaida K, Yoshihara S, Fujioka T, Taniguchi Y, Tamaki H, Inoue T, Hasei H, Iiboshi Y, Tazuke Y, Kawakami M, Kim EH, Soma T, Inoue T, Kawase I (2008) Unmanipulated HLA 2–3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. Exp Hematol 36:1–8PubMedCrossRef Ogawa H, Ikegame K, Kaida K, Yoshihara S, Fujioka T, Taniguchi Y, Tamaki H, Inoue T, Hasei H, Iiboshi Y, Tazuke Y, Kawakami M, Kim EH, Soma T, Inoue T, Kawase I (2008) Unmanipulated HLA 2–3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. Exp Hematol 36:1–8PubMedCrossRef
25.
Zurück zum Zitat Katoh M, Yamasaki H (2009) Comparison of reliability of isometric leg muscle strength measurements made using a hand-held dynamometer with and without a restraining belt. J Phys Ther Sci 21:37–42CrossRef Katoh M, Yamasaki H (2009) Comparison of reliability of isometric leg muscle strength measurements made using a hand-held dynamometer with and without a restraining belt. J Phys Ther Sci 21:37–42CrossRef
26.
Zurück zum Zitat Katoh M, Yamasaki H (2009) Test-retest reliability of isometric leg muscle strength measurements made using a hand-held dynamometer restrained by a belt: comparisons during and between sessions. J Phys Ther Sci 21:239–243CrossRef Katoh M, Yamasaki H (2009) Test-retest reliability of isometric leg muscle strength measurements made using a hand-held dynamometer restrained by a belt: comparisons during and between sessions. J Phys Ther Sci 21:239–243CrossRef
27.
Zurück zum Zitat ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117CrossRef ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117CrossRef
28.
Zurück zum Zitat Sciurba F, Criner G, Lee S, Mohsenifar Z, Shade D, Slivka W, Wise RA, National Emphysema Treatment Trial Research Group (2003) Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med 167:1522–1527PubMedCrossRef Sciurba F, Criner G, Lee S, Mohsenifar Z, Shade D, Slivka W, Wise RA, National Emphysema Treatment Trial Research Group (2003) Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med 167:1522–1527PubMedCrossRef
29.
Zurück zum Zitat Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25:677–684PubMed Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25:677–684PubMed
30.
Zurück zum Zitat Batchelor TT, Taylor LP, Thaler HT, Posner JB, DeAngelis LM (1997) Steroid myopathy in cancer patients. Neurology 48:1234–1238PubMedCrossRef Batchelor TT, Taylor LP, Thaler HT, Posner JB, DeAngelis LM (1997) Steroid myopathy in cancer patients. Neurology 48:1234–1238PubMedCrossRef
31.
Zurück zum Zitat Barry SC, Gallagher CG (2003) Corticosteroids and skeletal muscle function in cystic fibrosis. J Appl Physiol 95:1379–1384PubMed Barry SC, Gallagher CG (2003) Corticosteroids and skeletal muscle function in cystic fibrosis. J Appl Physiol 95:1379–1384PubMed
32.
Zurück zum Zitat Minetto MA, Lanfranco F, Motta G, Allasia S, Arvat E, D’Antona G (2011) Steroid myopathy: some unresolved issues. J Endocrinol Invest 34:370–375PubMed Minetto MA, Lanfranco F, Motta G, Allasia S, Arvat E, D’Antona G (2011) Steroid myopathy: some unresolved issues. J Endocrinol Invest 34:370–375PubMed
33.
Zurück zum Zitat Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Kleindienst N, Ulrich CM, Bohus M (2011) Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood 117:2604–2613PubMedCrossRef Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Kleindienst N, Ulrich CM, Bohus M (2011) Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood 117:2604–2613PubMedCrossRef
34.
Zurück zum Zitat Jarden M, Baadsgaard M, Hovgaard D, Boesen E, Adamsen L (2009) A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant 43:725–737PubMedCrossRef Jarden M, Baadsgaard M, Hovgaard D, Boesen E, Adamsen L (2009) A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant 43:725–737PubMedCrossRef
35.
Zurück zum Zitat Baumann FT, Kraut L, Schüle K, Bloch W, Fauser AA (2010) A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant 45:355–362PubMedCrossRef Baumann FT, Kraut L, Schüle K, Bloch W, Fauser AA (2010) A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant 45:355–362PubMedCrossRef
36.
Zurück zum Zitat Angst F, Drerup S, Werle S, Herren DB, Simmen BR, Goldhahn J (2010) Prediction of grip and key pinch strength in 978 healthy subjects. BMC Musculoskelet Disord 11:94PubMedCrossRef Angst F, Drerup S, Werle S, Herren DB, Simmen BR, Goldhahn J (2010) Prediction of grip and key pinch strength in 978 healthy subjects. BMC Musculoskelet Disord 11:94PubMedCrossRef
37.
Zurück zum Zitat Bohannon RW (1997) Reference values for extremity muscle strength obtained by hand-held dynamometry from adults aged 20 to 79 years. Arch Phys Med Rehabil 78:26–32PubMedCrossRef Bohannon RW (1997) Reference values for extremity muscle strength obtained by hand-held dynamometry from adults aged 20 to 79 years. Arch Phys Med Rehabil 78:26–32PubMedCrossRef
38.
Zurück zum Zitat Poh H, Eastwood PR, Cecins NM, Ho KT, Jenkins SC (2006) Six-minute walk distance in healthy Singaporean adults cannot be predicted using reference equations derived from Caucasian populations. Respirology 11:211–216PubMedCrossRef Poh H, Eastwood PR, Cecins NM, Ho KT, Jenkins SC (2006) Six-minute walk distance in healthy Singaporean adults cannot be predicted using reference equations derived from Caucasian populations. Respirology 11:211–216PubMedCrossRef
39.
Zurück zum Zitat Morishita S, Kaida K, Ikegame K, Yoshihara S, Taniguchi K, Okada M, Kodama N, Ogawa H, Domen K (2012) Impaired physiological function and health-related QOL in patients before hematopoietic stem-cell transplantation. Support Care Cancer 20:821–829PubMedCrossRef Morishita S, Kaida K, Ikegame K, Yoshihara S, Taniguchi K, Okada M, Kodama N, Ogawa H, Domen K (2012) Impaired physiological function and health-related QOL in patients before hematopoietic stem-cell transplantation. Support Care Cancer 20:821–829PubMedCrossRef
40.
Zurück zum Zitat Bevans M, Wehrlen L, Prachenko O, Soeken K, Zabora J, Wallen GR (2011) Distress screening in allogeneic hematopoietic stem cell (HSCT) caregivers and patients. Psychooncology 20:615–622PubMedCrossRef Bevans M, Wehrlen L, Prachenko O, Soeken K, Zabora J, Wallen GR (2011) Distress screening in allogeneic hematopoietic stem cell (HSCT) caregivers and patients. Psychooncology 20:615–622PubMedCrossRef
41.
Zurück zum Zitat Morishita S, Kaida K, Tanaka T, Itani Y, Ikegame K, Okada M, Ishii S, Kodama N, Ogawa H, Domen K (2012) Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. Support Care Cancer 20:3161–3168PubMedCrossRef Morishita S, Kaida K, Tanaka T, Itani Y, Ikegame K, Okada M, Ishii S, Kodama N, Ogawa H, Domen K (2012) Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. Support Care Cancer 20:3161–3168PubMedCrossRef
42.
Zurück zum Zitat Calbet J, Lundby C, Koskolou M, Boushel R (2006) Importance of hemoglobin concentration to exercise: acute manipulations. Respir Physiol Neurobiol 151:132–140PubMedCrossRef Calbet J, Lundby C, Koskolou M, Boushel R (2006) Importance of hemoglobin concentration to exercise: acute manipulations. Respir Physiol Neurobiol 151:132–140PubMedCrossRef
43.
Zurück zum Zitat Bellotto F, Palmisano P, Compostella L, Russo N, Zaccaria M, Guida P, Setzu T, Cati A, Maddalozzo A, Favale S, Iliceto S (2011) Anemia does not preclude increments in cardiac performance during a short period of intensive, exercise-based cardiac rehabilitation. Eur J Cardiovasc Prev Rehabil 18:150–157PubMedCrossRef Bellotto F, Palmisano P, Compostella L, Russo N, Zaccaria M, Guida P, Setzu T, Cati A, Maddalozzo A, Favale S, Iliceto S (2011) Anemia does not preclude increments in cardiac performance during a short period of intensive, exercise-based cardiac rehabilitation. Eur J Cardiovasc Prev Rehabil 18:150–157PubMedCrossRef
44.
Zurück zum Zitat Alameri HF, Sanai FM, Al Dukhayil M, Azzam NA, Al-Swat KA, Hersi AS, Abdo AA (2007) Six minute walk test to assess functional capacity in chronic liver disease patients. World J Gastroenterol 13:3996–4001PubMed Alameri HF, Sanai FM, Al Dukhayil M, Azzam NA, Al-Swat KA, Hersi AS, Abdo AA (2007) Six minute walk test to assess functional capacity in chronic liver disease patients. World J Gastroenterol 13:3996–4001PubMed
Metadaten
Titel
Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients
verfasst von
Shinichiro Morishita
Katsuji Kaida
Shinya Yamauchi
Koichiro Sota
Shinichi Ishii
Kazuhiro Ikegame
Norihiko Kodama
Hiroyasu Ogawa
Kazuhisa Domen
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1778-7

Weitere Artikel der Ausgabe 8/2013

Supportive Care in Cancer 8/2013 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.